A major clinical trial has found Boston Scientific’s Farapulse pulsed-field ablation nearly doubles the success rate of treating persistent atrial fibrillation compared with medication. One year after ...

HEART PROCEDURE SUPERIOR TO DRUGS FOR COMMON ARRHYTHMIA A minimally invasive procedure that “rewires” ‌the heart may be a ...

In patients with persistent atrial fibrillation, those receiving pulsed field ablation as first-line therapy had less risk ...

A major international trial has found that pulsed-field catheter ablation offers superior outcomes to antiarrhythmic drugs for patients with persistent atrial fibrillation. One year after treatment, ...

Atrial fibrillation, often called AFib, is a condition that affects the rhythm of the heart. Instead of beating in a steady ...

In the single-arm FULCRUM-VT trial, 59% of patients remained free of recurrent VT at 6 months, with less amiodarone use.

The "father of modern cardiology" Eugene Braunwald, MD, died at the age of 96, and he was honored with obituaries from the ...

Two retrospective studies detected arrhythmias beyond 48 hours in 30% of patients post cardiac ablation and in 60% of ...

Over the last weekend, Chicago played host to the 2026 edition of the Heart Rhythm Society's annual conference (HRS 2026).

A common heart condition called atrial fibrillation, often shortened to AFib, affects millions of people around the world. It ...

Pulse Biosciences ( (PLSE)) just unveiled an update. On April 25, 2026, Pulse Biosciences reported updated late‑breaking data from its first‑in‑human feasibility study of the nPulse Cardiac Catheter ...

Medtronic announces key Affera clinical study milestones for Sphere-9 and Sphere-360 catheters as global adoption continues: Galway, Ireland Tuesday, April 28, 2026, 11:00 Hrs [IS ...